tirzepatide weight loss in 3 months Our management program: 12 of semaglutide, 7 months of Adults with obesity who discontinue

Apart from these cautionary suggestions/recommendations, there is little direct scientific evidence to suggest that there is reason to exercise caution regarding TRZD administration, possibly concerning cancer (pancreatic and thyroid) incidence and progression

The event rates ranged from 0.7 to 1.3 per 1,000 patient-years with the DPP-4 inhibitors and from 0.3 to 1.7 per 1,000 patient-years with the comparators

Participants with T2DM also showed improved HbA1c levels and favorable lipid profile changes (Kapitza et al., 2023)

And if you are considering switching between the two, the conversion chart maps equivalent doses